# A Clinical Study to Determine the Safety and Efficacy of an Oral Supplementation of Bio-Immune®for Managing Upper Respiratory Tract Infection and Its Symptoms.

> **NCT06689995** · NA · COMPLETED · sponsor: **NovoBliss Research Pvt Ltd** · enrollment: 56 (actual)

## Conditions studied

- Upper Respiratory Tract Infection

## Interventions

- **OTHER:** Bio-immune Capsule
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06689995
- **Lead sponsor:** NovoBliss Research Pvt Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-30
- **Primary completion:** 2025-01-29
- **Final completion:** 2025-01-29
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06689995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06689995, "A Clinical Study to Determine the Safety and Efficacy of an Oral Supplementation of Bio-Immune®for Managing Upper Respiratory Tract Infection and Its Symptoms.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06689995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*